Publications en collaboration avec des chercheurs de Hospital Universitario Araba (15)

2023

  1. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  2. Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 1-25

2022

  1. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

2019

  1. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

2018

  1. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis

    Journal of Infection and Chemotherapy, Vol. 24, Núm. 7, pp. 555-562

2017

  1. Infective endocarditis in patients with cancer: A consequence of invasive procedures or a harbinger of neoplasm? A prospective, multicenter cohort

    Medicine (United States), Vol. 96, Núm. 38

  2. Nationwide study on peripheral-venous-catheter-associated-bloodstream infections in internal medicine departments

    Journal of Hospital Infection, Vol. 97, Núm. 3, pp. 260-266

2015

  1. Current epidemiology and outcome of infective endocarditis: A multicenter, prospective, cohort study

    Medicine (United States), Vol. 94, Núm. 43

  2. Left-sided infective endocarditis in patients with liver cirrhosis

    Journal of Infection, Vol. 71, Núm. 6, pp. 627-641

  3. Nationwide study on the use of intravascular catheters in internal medicine departments

    Journal of Hospital Infection, Vol. 90, Núm. 2, pp. 135-141

2013

  1. Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy

    Medicina Intensiva, Vol. 37, Núm. 5, pp. 320-326

2008

  1. Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277

2007

  1. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229

2003

  1. Oral pharmacokinetically enhanced co-amoxiclav 2000/125 mg, twice daily, compared with co-amoxiclav 875/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adults

    Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 5, pp. 826-836

2002

  1. Meningitis neumocócica en niños Españoles: Incidencia, serotipos y resistencia antibiótica. Estudio prospectivo multicéntrico

    Anales Espanoles de Pediatria, Vol. 57, Núm. 4, pp. 295-300